Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia, Ventilator-Associated | 4 | 2023 | 41 | 2.520 |
Why?
|
| Veterans | 12 | 2023 | 1234 | 2.420 |
Why?
|
| Pneumonia | 3 | 2023 | 576 | 1.640 |
Why?
|
| Pain Management | 4 | 2019 | 291 | 1.150 |
Why?
|
| United States Department of Veterans Affairs | 12 | 2022 | 557 | 1.100 |
Why?
|
| Veterans Health | 6 | 2024 | 165 | 1.060 |
Why?
|
| Chronic Pain | 4 | 2024 | 210 | 0.920 |
Why?
|
| Cross Infection | 2 | 2021 | 202 | 0.820 |
Why?
|
| Kidney Diseases | 1 | 2022 | 354 | 0.630 |
Why?
|
| Health Services Accessibility | 4 | 2018 | 773 | 0.590 |
Why?
|
| Depression | 3 | 2021 | 1147 | 0.560 |
Why?
|
| Telemedicine | 4 | 2022 | 667 | 0.540 |
Why?
|
| Sepsis | 1 | 2022 | 515 | 0.530 |
Why?
|
| Percutaneous Coronary Intervention | 5 | 2022 | 445 | 0.500 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1098 | 0.410 |
Why?
|
| United States | 17 | 2024 | 12304 | 0.330 |
Why?
|
| Medication Adherence | 4 | 2015 | 538 | 0.330 |
Why?
|
| Hospitals, Veterans | 4 | 2018 | 245 | 0.310 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 845 | 0.260 |
Why?
|
| Risk Factors | 5 | 2023 | 8702 | 0.260 |
Why?
|
| Pandemics | 3 | 2024 | 1335 | 0.260 |
Why?
|
| beta-Alanine | 2 | 2015 | 18 | 0.240 |
Why?
|
| Humans | 30 | 2024 | 115741 | 0.240 |
Why?
|
| Antithrombins | 2 | 2015 | 49 | 0.240 |
Why?
|
| Myocardial Infarction | 4 | 2016 | 931 | 0.230 |
Why?
|
| Retrospective Studies | 10 | 2024 | 12633 | 0.230 |
Why?
|
| Patient Education as Topic | 4 | 2018 | 686 | 0.230 |
Why?
|
| Benzimidazoles | 2 | 2015 | 137 | 0.220 |
Why?
|
| Natural Language Processing | 1 | 2023 | 71 | 0.210 |
Why?
|
| Courage | 1 | 2022 | 2 | 0.210 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 465 | 0.200 |
Why?
|
| Quality Assurance, Health Care | 1 | 2023 | 315 | 0.190 |
Why?
|
| Erythrocyte Transfusion | 1 | 2023 | 187 | 0.190 |
Why?
|
| Myocardial Ischemia | 1 | 2022 | 237 | 0.180 |
Why?
|
| Community Health Services | 2 | 2019 | 213 | 0.180 |
Why?
|
| Acute Coronary Syndrome | 2 | 2014 | 254 | 0.170 |
Why?
|
| Administration, Inhalation | 1 | 2021 | 644 | 0.160 |
Why?
|
| Bronchodilator Agents | 1 | 2021 | 249 | 0.160 |
Why?
|
| Polysomnography | 1 | 2019 | 135 | 0.160 |
Why?
|
| Patient-Centered Care | 2 | 2015 | 477 | 0.160 |
Why?
|
| Vitamin D | 1 | 2022 | 341 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2023 | 6276 | 0.160 |
Why?
|
| Comorbidity | 3 | 2018 | 1473 | 0.160 |
Why?
|
| Aged | 11 | 2022 | 19294 | 0.150 |
Why?
|
| Myocardial Revascularization | 1 | 2018 | 67 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 509 | 0.150 |
Why?
|
| Qualitative Research | 1 | 2022 | 975 | 0.140 |
Why?
|
| Patient Discharge | 2 | 2014 | 770 | 0.140 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2016 | 19 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2018 | 196 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2023 | 805 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 233 | 0.130 |
Why?
|
| Self Care | 2 | 2018 | 354 | 0.130 |
Why?
|
| Spatial Analysis | 1 | 2016 | 20 | 0.130 |
Why?
|
| Middle Aged | 12 | 2019 | 27069 | 0.130 |
Why?
|
| Remote Consultation | 1 | 2015 | 42 | 0.120 |
Why?
|
| Incidence | 1 | 2021 | 2335 | 0.120 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 71 | 0.120 |
Why?
|
| Cardiac Care Facilities | 1 | 2014 | 13 | 0.120 |
Why?
|
| Anxiety | 1 | 2021 | 854 | 0.120 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 783 | 0.120 |
Why?
|
| Early Medical Intervention | 1 | 2015 | 51 | 0.120 |
Why?
|
| Atrial Fibrillation | 2 | 2015 | 325 | 0.120 |
Why?
|
| Hospitals | 2 | 2021 | 585 | 0.120 |
Why?
|
| Medicine | 1 | 2015 | 103 | 0.110 |
Why?
|
| Health Status | 2 | 2016 | 728 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2015 | 184 | 0.110 |
Why?
|
| Cohort Studies | 6 | 2024 | 4949 | 0.110 |
Why?
|
| Patient Care Team | 2 | 2015 | 521 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 119 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2015 | 257 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 399 | 0.110 |
Why?
|
| Heart Failure | 2 | 2016 | 1964 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2014 | 223 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 287 | 0.100 |
Why?
|
| Hospitalization | 3 | 2022 | 1765 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 249 | 0.100 |
Why?
|
| Patient Selection | 1 | 2015 | 654 | 0.100 |
Why?
|
| Thrombosis | 1 | 2014 | 302 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2014 | 331 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 125 | 0.090 |
Why?
|
| Male | 11 | 2022 | 56050 | 0.090 |
Why?
|
| Cardiac Catheterization | 1 | 2014 | 538 | 0.090 |
Why?
|
| Stents | 1 | 2014 | 477 | 0.090 |
Why?
|
| Longitudinal Studies | 4 | 2022 | 2420 | 0.090 |
Why?
|
| Female | 11 | 2022 | 60018 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 607 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 1180 | 0.080 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 250 | 0.070 |
Why?
|
| Registries | 1 | 2014 | 1770 | 0.070 |
Why?
|
| Adult | 5 | 2019 | 30789 | 0.070 |
Why?
|
| Research Design | 1 | 2012 | 946 | 0.070 |
Why?
|
| Travel | 2 | 2018 | 121 | 0.070 |
Why?
|
| Stroke | 1 | 2014 | 1017 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2014 | 2990 | 0.060 |
Why?
|
| Asthma | 1 | 2018 | 2066 | 0.060 |
Why?
|
| Dabigatran | 2 | 2015 | 22 | 0.060 |
Why?
|
| Quality of Life | 1 | 2015 | 2388 | 0.060 |
Why?
|
| Time Factors | 4 | 2016 | 6171 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2014 | 2164 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2022 | 9162 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 1754 | 0.060 |
Why?
|
| Technology | 1 | 2024 | 80 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2023 | 38 | 0.050 |
Why?
|
| Interdisciplinary Communication | 2 | 2015 | 185 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 148 | 0.050 |
Why?
|
| Minority Groups | 1 | 2024 | 230 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1441 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2016 | 618 | 0.050 |
Why?
|
| Patient Readmission | 2 | 2018 | 609 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2022 | 307 | 0.040 |
Why?
|
| Complementary Therapies | 1 | 2019 | 73 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2023 | 589 | 0.040 |
Why?
|
| Communication | 1 | 2024 | 750 | 0.040 |
Why?
|
| Occupational Therapy | 1 | 2019 | 73 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 1218 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 117 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 200 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 154 | 0.030 |
Why?
|
| Coronary Thrombosis | 1 | 2016 | 25 | 0.030 |
Why?
|
| Mental Health | 1 | 2022 | 571 | 0.030 |
Why?
|
| Drug Utilization Review | 1 | 2016 | 57 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2016 | 52 | 0.030 |
Why?
|
| Hypesthesia | 1 | 2016 | 16 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 269 | 0.030 |
Why?
|
| Chest Pain | 1 | 2016 | 82 | 0.030 |
Why?
|
| Cost Savings | 1 | 2015 | 75 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 4442 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2015 | 79 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2014 | 64 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 116 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2018 | 576 | 0.030 |
Why?
|
| Pharmacists | 1 | 2015 | 237 | 0.030 |
Why?
|
| Medication Reconciliation | 1 | 2012 | 25 | 0.030 |
Why?
|
| Disease Management | 1 | 2016 | 563 | 0.020 |
Why?
|
| Community Pharmacy Services | 1 | 2012 | 45 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1139 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 258 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2012 | 162 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2269 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 390 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 548 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2012 | 384 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3343 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4448 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 4669 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 1200 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6423 | 0.010 |
Why?
|